Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer
Maryam B. Lustberg(Yale Cancer Center), Charles L. Shapiro(Tisch Hospital), Ewa Mrózek(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Donna R. Shiels(The Ohio State University), Rebecca M. Ziegler(Oklahoma State University Medical Center), Rachel M. Layman(The University of Texas MD Anderson Cancer Center), Bhuvaneswari Ramaswamy(The Ohio State University), Robert W. Brueggemeier(The Ohio State University), Weiqiang Zhao(Harbin Institute of Technology), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Stephen P. Povoski(The Ohio State University), Amy M. Lehman(The Ohio State University), Y. Sugimoto
Cited by 27
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k